Priority Date: 19.04.12 (US 201261687114P)

GLUFOSFAMIDE COMBINATION THERAPIES FOR CANCER

  • Application ID: EP12874672
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 11 - 50 employees
Company dna abg patentes sl
operating since 2003
Headquarter in Madrid and 1 office
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A01 (AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING) and A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) is specialized in the combination A01 and A61. We found, that Coller IP Management Ltd, Sperling Fischer & Heyner, Zacco Denmark A/S, Isenbruck Bösl Hörschler LLP, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB and 89 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 19.04.2012 - Priority Date (US 201261687114P)
  • 24.10.2013 - Publication A1 (WO2013158143)
  • 18.03.2015 - Publication A1 (EP2846638)

IPC Classification